Drug profile · INN
acetylcholine chloride
MIOCHOL
acetylcholine chloride (MIOCHOL) is a muscarinic acetylcholine receptor m3 agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — acetylcholine chloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 1
- Programs
- 2
- Data quality
- 0.84
Quick answer
acetylcholine chloride (MIOCHOL) is a muscarinic acetylcholine receptor m3 agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 agonist
Primary target: Muscarinic acetylcholine receptor M3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is acetylcholine chloride?
acetylcholine chloride (MIOCHOL) is a muscarinic acetylcholine receptor m3 agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for acetylcholine chloride?
MIOCHOL is a marketed brand name for acetylcholine chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetylcholine chloride?
acetylcholine chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.